Healthcare burden associated with the post-thrombotic syndrome and potential impact of the new oral anticoagulants

Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis

(2013) Susan R. Kahn   ANNALS OF INTERNAL MEDICINE

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

(2011) Elise S. Eerenberg et al.   CIRCULATION

Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa

(2011) K. A. BAUER   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Postthrombotic syndrome and quality of life in patients with iliofemoral venous thrombosis treated with catheter-directed thrombolysis

(2011) Rikke Broholm et al.   JOURNAL OF VASCULAR SURGERY

The new oral anticoagulants

(2011) F. W. A. Verheugt   Netherlands Heart Journal

Economic burden of venous thromboembolism: a systematic review

(2011) Andras Ruppert et al.   JOURNAL OF MEDICAL ECONOMICS

Quantification of Apixaban's Therapeutic Utility in Prevention of Venous Thromboembolism: Selection of Phase III Trial Dose

(2010) T A Leil et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacologic Properties of the New Oral Anticoagulants: A Clinician-oriented Review with a Focus on Perioperative Management

(2010) James D. Douketis   CURRENT PHARMACEUTICAL DESIGN

Factors Predicting Development of Post-thrombotic Syndrome in Patients with a First Episode of Deep Vein Thrombosis: Preliminary Report

(2010) T. Yamaki et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Insights from the dabigatran versus warfarin trial in patients with venous thromboembolism (the RE-COVER trial)

(2010) Paolo Prandoni et al.   EXPERT OPINION ON PHARMACOTHERAPY

The need for new oral anticoagulants in clinical practice

(2010) Elaine M Hylek   Journal of Cardiovascular Medicine

New antithrombotic agents—insights from clinical trials

(2010) Jeremy S. Paikin et al.   Nature Reviews Cardiology

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

(2010) Elisabeth Perzborn et al.   NATURE REVIEWS DRUG DISCOVERY

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development

(2010) Mike Ufer   THROMBOSIS AND HAEMOSTASIS

New oral anticoagulant drugs in cardiovascular disease

(2010) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: Comparison with direct inhibitors of factor VIIa, XIa and thrombin

(2010) Xiaosui Jiang et al.   THROMBOSIS AND HAEMOSTASIS

Home Therapy of Venous Thrombosis with Long-term LMWH versus Usual Care: Patient Satisfaction and Post-thrombotic Syndrome

(2009) Russell D. Hull et al.   AMERICAN JOURNAL OF MEDICINE

Use of Emerging Oral Anticoagulants in Clinical Practice

(2009) Geno Merli et al.   ANNALS OF SURGERY

How I treat postthrombotic syndrome

(2009) S. R. Kahn   BLOOD

The new oral anticoagulants

(2009) D. Garcia et al.   BLOOD

Post-thrombotic syndrome: prevalence, prognostication and need for progress

(2009) Paolo Prandoni et al.   BRITISH JOURNAL OF HAEMATOLOGY

Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans

(2009) C. Weinz et al.   DRUG METABOLISM AND DISPOSITION

In Vitro Metabolism of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Liver Microsomes and Hepatocytes of Rats, Dogs, and Humans

(2009) D. Lang et al.   DRUG METABOLISM AND DISPOSITION

The postthrombotic syndrome

(2009) Raffaele Pesavento et al.   Internal and Emergency Medicine

Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome

(2009) S. R. KAHN   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization

(2009) S. R. KAHN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Newer anticoagulants in 2009

(2009) Meyer Michel Samama et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Incidence and cost burden of post-thrombotic syndrome

(2009) Aneel A. Ashrani et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

New oral anticoagulants: a practical guide for clinicians

(2009) Ann K. Wittkowsky   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

(2009) Sam Schulman et al.   NEW ENGLAND JOURNAL OF MEDICINE

The clinical implications of new oral anticoagulants: Will the potential advantages be achieved?

(2009) K. W. Phillips et al.   THROMBOSIS AND HAEMOSTASIS

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study

(2008) H. R. Buller et al.   BLOOD

Antithrombotic Therapy for Venous Thromboembolic Disease

(2008) Clive Kearon et al.   CHEST

Pharmacology and Management of the Vitamin K Antagonists

(2008) Jack Ansell et al.   CHEST

Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development

(2008) Bengt I Eriksson et al.   CLINICAL PHARMACOKINETICS

Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects

(2008) Dagmar Kubitza et al.   CURRENT MEDICAL RESEARCH AND OPINION

Apixaban, an oral direct Factor Xa inhibitor: awaiting the verdict

(2008) Jennifer Carreiro et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis

(2008) L. W. TICK et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Determinants of health-related quality of life during the 2 years following deep vein thrombosis

(2008) S. R. KAHN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin

(2008) José A. González-Fajardo et al.   JOURNAL OF VASCULAR SURGERY

The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms

(2008) Nicos Labropoulos et al.   JOURNAL OF VASCULAR SURGERY